Better Context Better Decisions

Context counts in life sciences. The Celltelligence analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access can use our library to search all of the content already delivered to their inbox. If you think a colleague would enjoy receiving our content, reach out to Mark to make it happen.

Free
Posted in: Autologous, CAR-T, CD19 Apr 04 | 2022Thoughts on Yescarta's FDA Approval in 2L LBCLAccess Free Blast
Free
Posted in: Autologous, CAR-T, CD19 Mar 25 | 2022Breyanzi’s sNDA Accepted in Japan for 2L DLBCLAccess Free Blast
Free
Posted in: Allogeneic, Autologous, CAR-T Mar 24 | 2022Thoughts on Chinese CAR-T Ambitions after Lilly CRL and ODACAccess Free Blast
1 2 3 4 16

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Mark.